Canada: Leamington medical cannabis producer pledges $100K for osteoarthritis research

Warning message

The subscription service is currently unavailable. Please try again later.

An Essex County medical marijuana producer has pledged $100,000 to the Arthritis Society for research on marijuana as treatment for osteoarthritis.

Leamington-based Aphria Inc.  is one of two licensed producers from Ontario that pledged $100,000 each to fund the first robust investigation on medical cannabis’ impact on arthritis pain management.

“The research right now is reasonably experimental, we have a lot of anecdotal information, but not a lot of hard evidence to be able to say that from a pain and inflammation perspective, medical cannabis is the right treatment and safe and effective,” said Joanne Simons, chief missions officer of the Arthritis Society.

Simons said the Arthritis Society was in full control of the recipient of the research grant and neither of the marijuana suppliers, the other being Peace Naturals Project from Stayner, Ont., had the ability to designate where the money was directed.

Over three years, $120,000 will go towards research...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://blogs.windsorstar.com/news/leamington-medical-cannabis-producer-pledges-100k-for-osteoarthritis-research